Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page:

HBA2 gene

hemoglobin subunit alpha 2

Normal Function

The HBA2 gene provides instructions for making a protein called alpha-globin. This protein is also produced from a nearly identical gene called HBA1. These two alpha-globin genes are located close together in a region of chromosome 16 known as the alpha-globin locus.

Alpha-globin is a component (subunit) of a larger protein called hemoglobin, which is the protein in red blood cells that carries oxygen to cells and tissues throughout the body. Hemoglobin is made up of four subunits: two subunits of alpha-globin and two subunits of another type of globin. Alpha-globin is a component of both fetal hemoglobin, which is active only before birth and in the newborn period, and adult hemoglobin, which is active throughout the rest of life.

Each of the four protein subunits of hemoglobin carries an iron-containing molecule called heme. Heme molecules are necessary for red blood cells to pick up oxygen in the lungs and deliver it to the body's tissues. A complete hemoglobin protein is capable of carrying four oxygen molecules at a time (one attached to each heme molecule). Oxygen attached to hemoglobin gives blood its bright red color.

Health Conditions Related to Genetic Changes

Alpha thalassemia

Deletions of the HBA1 and/or HBA2 genes are the most common cause of alpha thalassemia. Less commonly, variants (also called mutations) in or near these genes cause the condition. The signs and symptoms of alpha thalassemia tend to be more severe when the disease results from variants in the alpha-globin genes than when it is caused by deletions of these genes.

People have two copies of the HBA1 gene and two copies of the HBA2 gene in each cell. Each copy is called an allele. For each gene, one allele is inherited from a person's father, and the other is inherited from a person's mother. As a result, there are four alleles that produce alpha-globin. The different types of alpha thalassemia result from the loss of some or all of these alleles.

Deletions and variants affecting one or more alleles reduce the amount of alpha-globin cells produce. Variants tend to reduce alpha-globin more than deletions.

Hb Bart syndrome, the most severe form of alpha thalassemia, results from the loss or alteration of all four alpha-globin alleles. This condition is characterized by a buildup of excess fluid in the body before birth (hydrops fetalis), a shortage of red blood cells (anemia), and an enlarged liver and spleen (hepatosplenomegaly).

HbH disease, which is milder, is usually caused by a loss of three of the four alpha-globin alleles. Because variants affecting HBA1 or HBA2 can be more severe than deletions, variants in two of the four alpha-globin alleles can result in HbH disease. HbH disease is characterized by mild to moderate anemia, hepatosplenomegaly, and yellowing of the eyes and skin (jaundice).

In Hb Bart syndrome and HbH disease, a shortage of alpha-globin hinders the production of normal hemoglobin. Instead, cells produce abnormal forms of hemoglobin called hemoglobin Bart (Hb Bart) or hemoglobin H (HbH). These abnormal hemoglobin molecules cannot effectively carry oxygen to the body's tissues. The substitution of Hb Bart or HbH for normal hemoglobin causes anemia and the other serious health problems associated with alpha thalassemia.

Two additional forms of alpha thalassemia are related to a reduced amount of alpha-globin. Because cells still produce some normal hemoglobin, these forms tend to cause few or no health problems. A loss of two of the four alpha-globin alleles results in alpha thalassemia trait. People with alpha thalassemia trait may have unusually small, pale red blood cells and mild anemia. A loss of one alpha-globin allele is found in alpha thalassemia silent carriers. These individuals typically have no thalassemia-related signs or symptoms.

Variants in one or two alpha-globin alleles cause a range of conditions, from alpha thalassemia silent carrier to HbH disease, depending on the alleles involved.

More About This Health Condition

Other disorders

A condition called  alpha-thalassemia-intellectual disability syndrome, chromosome 16-related (ATR-16) results from a large deletion of genetic material from the short (p) arm of chromosome 16. The signs and symptoms of this condition result from the loss of many genes, including HBA1 and HBA2.

A deletion of the HBA1 and HBA2 genes leads to alpha thalassemia trait in most people with ATR-16. The loss of other genes causes additional features of the disorder, including intellectual disability, severely delayed language skills, an unusually small head size (microcephaly), and distinctive facial features. Affected males may also have undescended testes (cryptorchidism) and the urethra opening on the underside of the penis (hypospadias).

The signs and symptoms of ATR-16 vary depending on the size of the deletion. A particularly large deletion may include the PKD1 gene, which is responsible for polycystic kidney disease. A loss of this gene leads to the growth of multiple cysts in the kidneys. If the deletion also includes the TSC2 gene, an affected individual will develop tuberous sclerosis complex. This condition is characterized by the growth of noncancerous tumors in many parts of the body.

Other Names for This Gene

  • alpha 2 globin
  • alpha globin
  • alpha-2 globin
  • alpha-globin locus, second
  • HBA-T2
  • hemoglobin, alpha 2
  • hemoglobin-alpha locus 2
  • major alpha-globin locus

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Gene and Variant Databases


  • Harteveld CL, Kriek M, Bijlsma EK, Erjavec Z, Balak D, Phylipsen M, Voskamp A, di Capua E, White SJ, Giordano PC. Refinement of the genetic cause of ATR-16. Hum Genet. 2007 Nov;122(3-4):283-92. doi: 10.1007/s00439-007-0399-y. Epub 2007 Jun 28. Citation on PubMed
  • Harvard University: Hemoglobin Synthesis
  • Higgs DR, Weatherall DJ. The alpha thalassaemias. Cell Mol Life Sci. 2009 Apr;66(7):1154-62. doi: 10.1007/s00018-008-8529-9. Citation on PubMed
  • Kalle Kwaifa I, Lai MI, Md Noor S. Non-deletional alpha thalassaemia: a review. Orphanet J Rare Dis. 2020 Jun 29;15(1):166. doi: 10.1186/s13023-020-01429-1. Citation on PubMed
  • Ribeiro DM, Sonati MF. Regulation of human alpha-globin gene expression and alpha-thalassemia. Genet Mol Res. 2008 Oct 14;7(4):1045-53. doi: 10.4238/vol7-4gmr472. Citation on PubMed
  • Tamary H, Dgany O. Alpha-Thalassemia. 2005 Nov 1 [updated 2024 May 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from Citation on PubMed
  • Zhang HB, Liu DP, Liang CC. The control of expression of the alpha-globin gene cluster. Int J Hematol. 2002 Dec;76(5):420-6. doi: 10.1007/BF02982807. Citation on PubMed

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.